Composition
- Active ingredients
- INSULIN ASPART 90 UNITS/3ML; INSULIN DEGLUDEC 210 UNITS/3ML (30 UNITS/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA203313.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ryzodeg 70/30
- Active substance
- insulin aspart
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Novo
- Status
- Discontinued
- FDA approval
- 25 Sept 2015
- Application
- BLA203313-001